Cargando…

Can Cell Bound Complement Activation Products Predict Inherited Complement Deficiency in Systemic Lupus Erythematosus?

Activation of the classical pathway complement system has long been implicated in stimulating immune complex mediated tissue destruction in systemic lupus erythematosus (SLE). C3 and C4 complement levels are utilized as part of SLE diagnosis and monitoring criteria. Recently, cell bound complement a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raj, Naveen, Waters, Barry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198155/ https://www.ncbi.nlm.nih.gov/pubmed/28074166 http://dx.doi.org/10.1155/2016/8219317

Ejemplares similares

Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation products
por: Wallace, Daniel J, et al.
Publicado: (2016)

The Avise Lupus Test and Cell-bound Complement Activation Products Aid the Diagnosis of Systemic Lupus Erythematosus
por: Mossell, James, et al.
Publicado: (2016)

Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurements
por: Putterman, Chaim, et al.
Publicado: (2014)

Complement deficiencies and susceptibility to systemic lupus erythematosus revisited
por: Elkon, KB, et al.
Publicado: (2012)

Complement deficiency in pediatric-onset systemic lupus erythematosus
por: Afzali, Parisa, et al.
Publicado: (2018)

Complement and systemic lupus erythematosus
por: Walport, Mark J
Publicado: (2002)

Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway
por: Macedo, Ana Catarina Lunz, et al.
Publicado: (2016)

Complement as a Biomarker for Systemic Lupus Erythematosus
por: Ayano, Masahiro, et al.
Publicado: (2023)

A multianalyte assay panel with cell-bound complement activation products demonstrates clinical utility in systemic lupus erythematosus
por: Alexander, Roberta Vezza, et al.
Publicado: (2021)

Coagulation cascade and complement system in systemic lupus erythematosus
por: Liang, Yan, et al.
Publicado: (2017)

DEFICIENCY OF THE FIFTH COMPONENT OF COMPLEMENT IN MICE WITH AN INHERITED COMPLEMENT DEFECT
por: Nilsson, Ulf R., et al.
Publicado: (1967)

DEFICIENCY OF THE SIXTH COMPONENT OF COMPLEMENT IN RABBITS WITH AN INHERITED COMPLEMENT DEFECT
por: Rother, Klaus, et al.
Publicado: (1966)

Cell-bound complement activation products associate with lupus severity in SLE
por: Arriens, Cristina, et al.
Publicado: (2020)

Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus
Publicado: (1982)

Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology–Classified Systemic Lupus Erythematosus
por: Ramsey‐Goldman, Rosalind, et al.
Publicado: (2019)

No association of complement mannose-binding lectin deficiency with cardiovascular disease in patients with Systemic Lupus Erythematosus
por: Kieninger-Gräfitsch, A., et al.
Publicado: (2020)

Inherited defects in the complement system
por: Leonardi, Lucia, et al.
Publicado: (2022)

Reduction in erythrocyte-bound complement activation products and titres of anti-C1q antibodies associate with clinical improvement in systemic lupus erythematosus
por: Buyon, Jill, et al.
Publicado: (2016)

HDL Cholesterol Efflux and the Complement System Are Linked in Systemic Lupus Erythematosus
por: García-González, María, et al.
Publicado: (2023)

The Role of Apoptosis Proteins and Complement Components in the Etiopathogenesis of Systemic Lupus Erythematosus
por: Liphaus, Bernadete L., et al.
Publicado: (2010)

Complement levels and risk of organ involvement in patients with systemic lupus erythematosus
por: Gandino, Ignacio Javier, et al.
Publicado: (2017)

Serum complement factor I is associated with disease activity of systemic lupus erythematosus
por: Tseng, Min-Hua, et al.
Publicado: (2018)

Cell-bound complement activation products in SLE
por: Ramsey-Goldman, Rosalind, et al.
Publicado: (2017)

Full characterization of the three pathways of the complement system in patients with systemic lupus erythematosus
por: García-González, María, et al.
Publicado: (2023)

Autoantibodies against complement component C1q in systemic lupus erythematosus
por: Trendelenburg, Marten
Publicado: (2021)

Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients
por: Eissa, Eman, et al.
Publicado: (2021)

Platelets and the Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus or Antiphospholipid Syndrome
por: Vils, Signe Risbøl, et al.
Publicado: (2023)

A Multianalyte Assay Panel With Cell‐Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology–Classified Lupus
por: Ramsey‐Goldman, Rosalind, et al.
Publicado: (2021)

Platelet Activation and Anti-Phospholipid Antibodies Collaborate in the Activation of the Complement System on Platelets in Systemic Lupus Erythematosus
por: Lood, Christian, et al.
Publicado: (2014)

Complement-4 Deficiency in a Child with Systemic Lupus Erythematosus Presenting with Standard Treatment-Resistant Severe Skin Lesion
por: Sozeri, Betul, et al.
Publicado: (2011)

Strong Association of Combined Genetic Deficiencies in the Classical Complement Pathway With Risk of Systemic Lupus Erythematosus and Primary Sjögren's Syndrome
por: Lundtoft, Christian, et al.
Publicado: (2022)

Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing
por: Douglas, Katherine B., et al.
Publicado: (2009)

Association between IgG4 Autoantibody and Complement Abnormalities in Systemic Lupus Erythematosus
por: Pan, Qingjun, et al.
Publicado: (2016)

A link between complement activation and anti-SSA in immune complex-induced cytokine production in systemic lupus erythematosus
por: Mathsson, L, et al.
Publicado: (2005)

Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus
por: Svenungsson, Elisabet, et al.
Publicado: (2020)

Enrichment of Complement, Immunoglobulins, and Autoantibody Targets in the Proteome of Platelets from Patients with Systemic Lupus Erythematosus
por: Linge, Carl Petrus, et al.
Publicado: (2022)

Identification of a novel mutation in complement receptor 2 in Chinese familial systemic lupus erythematosus
por: Tang, Yuewu, et al.
Publicado: (2022)

IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production
por: Pan, Qingjun, et al.
Publicado: (2020)

Serological and Genetic Evidence for Altered Complement System Functionality in Systemic Lupus Erythematosus: Findings of the GAPAID Consortium
por: Prechl, József, et al.
Publicado: (2016)

Erythrocyte complement receptor 1 (ECR1) and erythrocyte-bound C4d (EC4d) in the prediction of poor pregnancy outcomes in systemic lupus erythematosus (SLE)
por: Conklin, John, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kmijqjk5r5bt8obl4oq6o37f6n